WOOJUNG BIO, Inc. Logo

WOOJUNG BIO, Inc.

Integrated R&D platform offering CRO services, lab construction, and biotech incubation.

215380 | KO

Overview

Corporate Details

ISIN(s):
KR7215380007
LEI:
Country:
South Korea
Address:
경기도 화성시 동탄기흥로 593-8 (영천동, 우정바이오 신약클러스터I), 화성시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

WOOJUNG BIO, Inc. is an integrated biopharmaceutical R&D solutions provider, operating as an open innovation platform for new drug development. The company's business is structured around three main pillars. Its Pre-clinical Contract Research Organization (CRO) delivers tailored services including efficacy studies, safety evaluations, and pharmaceutical analysis, utilizing its leading, AAALAC-accredited animal research facilities. The Engineering & Construction division provides comprehensive A-to-Z solutions for laboratory modernization, from design and construction of GMP facilities and clean rooms to ongoing maintenance. Additionally, its LAB CLOUD initiative functions as an R&D cluster, offering specialized labs, incubation, and acceleration support to biotech ventures and startups, facilitating the translation of innovative concepts into therapeutic applications.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-28 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 123.0 KB
2025-08-28 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 126.1 KB
2025-08-28 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-08-28 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-08-27 00:00
Major Shareholding Notification
최대주주변경
Korean 30.2 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.1 MB
2025-07-21 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-05-21 00:00
Board/Management Information
[기재정정]대표이사변경
Korean 14.6 KB
2025-05-16 00:00
Board/Management Information
대표이사변경
Korean 9.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 979.9 KB
2025-04-22 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 26.0 KB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 20.0 KB
2025-03-20 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 596.0 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 137.5 KB

Automate Your Workflow. Get a real-time feed of all WOOJUNG BIO, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for WOOJUNG BIO, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for WOOJUNG BIO, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Evaxion A/S Logo
Develops AI-powered, personalized vaccines for cancer and infectious diseases.
United States of America
EVAX
Evogene Ltd. Logo
AI-powered platform designing life-science solutions for health, ag, and industrial sectors.
Israel
EVGN
EXACT Therapeutics AS Logo
Biopharma firm using ultrasound to enhance drug delivery for oncology via its ACT® platform.
Norway
EXTX
Offers performance-based advertising and CPA solutions via Japan's largest affiliate network.
Japan
2461
Back-office outsourcing & consulting in accounting, finance, and HR for SMEs & sole proprietors.
Japan
4771
Foremost Clean Energy Ltd. Logo
Canadian explorer of uranium and lithium for the clean energy sector.
United States of America
FMST
Forte Biosciences, Inc. Logo
Clinical-stage biopharma developing FB102 for autoimmune diseases like celiac, vitiligo, & alopecia.
United States of America
FBRX
Fortrea Holdings Inc. Logo
Global CRO managing clinical trials for the biopharmaceutical and medical device industries.
United States of America
FTRE
FRIENDLY CORPORATION Logo
Offers digital solutions for business growth: web production, marketing, e-commerce, & incubation.
Japan
8209
FTAI Infrastructure Inc. Logo
Develops, acquires, and operates critical infrastructure in rail, ports, power, and gas.
United States of America
FIP

Talk to a Data Expert

Have a question? We'll get back to you promptly.